The 21 references in paper A. Belyaev M., L. Berstein M., D. Vasil’ev A., E. Kostromina V., L. Krasil’nikova A., P. Krzhivitskiy I., A. Mikhet’ko A., A. Mishchenko V., S. Novikov N., Z. Radzhabova A., D. Sinyachkina A., E. Tsyrlina V., А. Беляев М., Л. Берштейн М., Д. Васильев А., Е. Костромина В., Л. Красильникова А., П. Крживицкий И., А. Михетько А., А. Мищенко В., С. Новиков Н., З. Раджабова А., Д. Синячкина А., Е. Цырлина В. (2018) “«Петровский» диагностический балльный показатель риска злокачественности узла в щитовидной железе (Petrov Thyroid Cancer Score, PTCS) // Diagnostic score of malignancy risk in the people having a node in thyroid gland (Petrov Thyroid Cancer Score, PTCS)” / spz:neicon:ogsh:y:2018:i:1:p:17-23

1
Заридзе Д.Г. Проблема гипердиагностики в онкологии. В сб.: III Всероссийская конференция по фундаментальной онкологии. М.: НМИЦ онкологии им. Н.Н. Блохина, 2017. [Zaridze D.G. Problem of overdiagnosis in oncology. In: III Russian conference of Fundamental Oncology. Moscow: N.N. Blo khin NMRCO, 2017. (In Russ.)].
(check this in PDF content)
2
Hoang J.K., Nguyen X.V., Davies L. Overdiagnosis of thyroid cancer: answers to five key questions. Acad Radiol 2015;22(8):1024–9. DOI: 10.1016/j.acra.2015.01.019.
(check this in PDF content)
3
Park S.H., Lee B., Lee S. et al. A qualitative study of women's views on overdiagnosis and screening for thyroid cancer in Korea. BMC Cancer 2015;15:858. DOI: 10.1186/s12885-015-1877-6.
(check this in PDF content)
4
Sanabria A., Kowalski L.P., Shah J.P. et al. Growing incidence of thyroid carcinoma in recent years: factors underlying overdiagnosis. Head Neck 2018;40(4):855–66. DOI: 10.1002/hed.25029.
(check this in PDF content)
5
Tessler F.N., Middleton W.D., Grant E.G. et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol 2017;14(5):587–95. DOI: 10.1016/j.jacr.2017.01.046.
(check this in PDF content)
6
Cibas E.S., Ali S.Z. The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid 2017;27(11):1341–6. DOI: 10.1089/thy.2017.0500.
(check this in PDF content)
7
Yang B.R., Kim E.K., Moon H.J. et al. Qualitative and semiquantitative elastography for the diagnosis of intermediate suspicious thyroid nodules based on the American 2015 Thyroid Association Guidelines. J Ultrasound Med 2017; Oct 16. DOI: 10.1002/jum.14449.
(check this in PDF content)
8
Yamashita S., Suzuki S., Suzuki S. et al. Lessons from Fukushima: latest findings of thyroid cancer after the Fukushima nuclear power plant accident. Thyroid 2018;28(1): 11–22.; DOI: 10.1089/thy.2017.0283.
(check this in PDF content)
9
Russ G., Leboulleux S., Leenhardt L., Hegedüs L. Thyroid incidentalomas: epidemiology, risk stratification with ultrasound and workup. Eur Thyroid J 2014;3(3):154–63. DOI: 10.1159/000365289.
(check this in PDF content)
10
Синячкина Д.А. Оптимизация диагностических мероприятий и лечебной тактики при распространенном раке щитовидной железы: автореф. дис. ... канд. мед. наук. СПб., 2017. 21 с. [Sinyachkina D.A. Optimization of diagnostic procedures and treatment strategy in advanced thyroid cancer: author's abstract of dis. ... cand. of med. sciences. Saint Petersburg, 2017. 21 p. (In Russ.)].
(check this in PDF content)
11
Zheng J., Li C., Lu W. et al. Quantitative assessment of preoperative serum thyrotropin level and thyroid cancer. Oncotarget 2016;7(23):34918–29. DOI: 10.18632/ oncotarget.9201.
(check this in PDF content)
12
Nixon I.J., Suárez C., Simo R. et al. The impact of family history on non-medullary thyroid cancer. Eur J Surg Oncol 2016;42(10):1455–63. DOI: 10.1016/j. ejso.2016.08.006.
(check this in PDF content)
13
Zimmermann M.B., Galetti V. Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies. Thyroid Res 2015;8:8. DOI: 10.1186/s13044-015-0020-8.
(check this in PDF content)
14
Malaguarnera R., Vella V., Nicolosi M.L., Belfiore A. Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer? Front Endocrinol (Lausanne) 2017;8:314. DOI: 10.3389/ fendo.2017.00314.
(check this in PDF content)
15
Poller D.N., Glaysher S. Molecular pathology and thyroid FNA. Cytopathology 2017;28(6):475–81. DOI: 10.1111/ cyt.12492.
(check this in PDF content)
16
Baloch Z.W., Fleisher S., LiVolsi V.A., Gupta P.K. Diagnosis of “follicular neoplasm”: a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 2002;26(1):41–4.
(check this in PDF content)
17
Singaporewalla R.M., Hwee J., Lang T.U., Desai V. Clinico-pathological correlation of thyroid nodule ultrasound and cytology using the TIRADS and Bethesda сlassifications. World J Surg 2017;41(7):
(check this in PDF content)
18
7–11. DOI: 10.1007/s00268-0173919-5. 18. Борсуков А.В., Морозова Т.Г., Кова- лев А.В. и др. Стандартизированная методика компрессионной соноэластографии щитовидной железы. Эндокринная хирургия 2014;(1):55–61. [Borsukov A.V., Morozova T.G., Kovalev A.V. et al. A standardized method for compression sonoelastography of thyroid gland. Endokrinnaya khirurgiya = Endocrine Surgery 2014;(1):55–61. (In Russ.)]. DOI: 10.14341/serg2014(1)55–61.
(check this in PDF content)
19
Evans C., Tennant S., Perros P. Thyroglobulin in differentiated thyroid cancer. Clin Chim Acta 2015;444:310–7. DOI: 10.1016/j.cca.2014.10.035.
(check this in PDF content)
20
Treglia G., Muoio B., Giovanella L., Salvatori M. The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: an overview. Eur Arch Otorhinolaryngol 2013;270(6):1783–7. DOI: 10.1007/s00405-012-2205-2.
(check this in PDF content)
21
Samsonov R., Burdakov V., Shtam T. et al. Plasma exosomal miR-21 and miR-181a differentiates follicular from papillary thyroid cancer. Tumour Biol 2016;37(9):12011–21. DOI: 10.1007/
(check this in PDF content)